Longtime N.S. volunteer firefighter battling cancer won't receive compensation
When Bruce Masales was diagnosed with Stage 4 bladder cancer, he says the news came without warning.But as a longtime ...
Medscape7d
Patient With Prostate Cancer Develops Rare Penile Metastasis
A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...
Targeted Oncology5d
Dr. Galsky’s Perspectives on Subcutaneous ICI Dosing
An expert discusses how the availability of subcutaneous (SC) immune checkpoint inhibitors (ICI) for bladder cancer impacts ...
ascopubs.org29d
Impact of adding immunotherapy to chemotherapy for metastatic neuroendocrine bladder cancer in the National Cancer Database.
Trends and demographic disparities in the preferred place of death for bladder cancer patients in the United States (2000–2020): An analysis from the CDC database. This is an ASCO Meeting Abstract ...
Targeted Oncology5d
Updated Efficacy Shows Nivolumab Boosts Survival in High-Risk MIBC
During a live event, Sumanta K. Pal, MD, discusses the efficacy and safety findings from the CheckMate 274 trial of adjuvant ...
From cancer vaccines to COPD treatments, these 10 companies are developing innovative medicines
Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
CURE11d
Xtandi and Talzenna Therapy Shows Responses in Advanced Prostate Cancer
Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...
CURE12d
Four Things to Remember When Both Spouses Have Cancer
When my spouse and I both faced cancer, maintaining a positive attitude, seeking support, listening empathetically and ...
Medscape10d
Lymph Node-positive Bladder Cancer
N1 Single lymph node metastasis, 2 cm or less in greatest ... The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% ...
pharmaphorum5d
Genentech withdraws US indication of Tecentriq for bladder, urinary tract cancer
for the treatment of adult patients with certain types of metastatic bladder or urinary tract cancer. Following a consultation with the US Food and Drug Administration (FDA), and in accordance ...